By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
DailynewsegyptDailynewsegypt
  • Home
  • Business
    BusinessShow More
    Egypt to issue new bonds for climate, social goals
    Egypt to issue new bonds for climate, social goals
    September 27, 2023
    Saudi Public Investment Fund eyes stake in Palm Hills Development
    Saudi Public Investment Fund eyes stake in Palm Hills Development
    September 27, 2023
    UNDP, MBRF launch online learning initiative for Arab countries
    UNDP, MBRF launch online learning initiative for Arab countries
    September 27, 2023
    Egypt Post invests in Roaderz platform to enhance e-commerce, delivery services
    Egypt Post invests in Roaderz platform to enhance e-commerce, delivery services
    September 27, 2023
    GAFI to grant 45 more golden licences to boost investment
    GAFI to grant 45 more golden licences to boost investment
    September 27, 2023
  • Politics
    PoliticsShow More
    Egypt’s Irrigation Minister highlights climate challenges for water sector
    Egypt’s Irrigation Minister highlights climate challenges for water sector
    September 27, 2023
    CCCPA, Senghor University join forces for African peace, development
    CCCPA, Senghor University join forces for African peace, development
    September 27, 2023
    Arab League chief urges more funding, investment for food security
    Arab League chief urges more funding, investment for food security
    September 27, 2023
    Egypt denounces Houthi attack on Bahraini forces in Saudi Arabia
    Egypt denounces Houthi attack on Bahraini forces in Saudi Arabia
    September 27, 2023
    vPalestine urges international action to end Israeli occupation, crimes
    Palestine urges international action to end Israeli occupation, crimes
    September 26, 2023
  • Interviews
    InterviewsShow More
    Microsoft Egypt aims to provide advanced AI models, build solid AI ecosystem: Mirna Arif
    Microsoft Egypt aims to provide advanced AI models, build solid AI ecosystem: Mirna Arif
    September 18, 2023
    I love privacy, and I am not concerned about competition: Yasmine Sabry
    I love privacy, and I am not concerned about competition: Yasmine Sabry
    September 14, 2023
    Sustainability, digital transformation at the heart of our strategy: Heidelberg Materials Egypt
    Sustainability, digital transformation at the heart of our strategy: Heidelberg Materials Egypt
    September 12, 2023
    India welcomes Egypt's BRICS membership: Boosting trade, investment, and access to strategic commodities
    India welcomes Egypt’s BRICS membership: Boosting trade, investment, and access to strategic commodities
    September 11, 2023
    The box office is not a measure of success: Basma Hassan
    The box office is not a measure of success: Basma
    September 6, 2023
  • Culture
  • Opinion
  • Sports
  • Lifestyle
Reading: Sandoz, ECS to produce biosimilar for blood cancer medication
Share
Notification
Latest News
Egypt to issue new bonds for climate, social goals
Egypt to issue new bonds for climate, social goals
Business
Saudi Public Investment Fund eyes stake in Palm Hills Development
Saudi Public Investment Fund eyes stake in Palm Hills Development
Business
Egypt’s Irrigation Minister highlights climate challenges for water sector
Egypt’s Irrigation Minister highlights climate challenges for water sector
Politics Egypt
CCCPA, Senghor University join forces for African peace, development
CCCPA, Senghor University join forces for African peace, development
Politics
Arab League chief urges more funding, investment for food security
Arab League chief urges more funding, investment for food security
Politics Egypt
Aa
Aa
DailynewsegyptDailynewsegypt
  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle
  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle
Have an existing account? Sign In
Follow US
  • Advertise
© 2023 DNE News. All Rights Reserved.
Dailynewsegypt > Blog > Business > Sandoz, ECS to produce biosimilar for blood cancer medication
Business

Sandoz, ECS to produce biosimilar for blood cancer medication

Daily News Egypt
Last updated: 2020/10/21 at 12:05 AM
By Daily News Egypt 4 Min Read
Share
SHARE

Sandoz Egypt announced that it has partnered with the Egyptian Cancer Society (ECS) to launch rituximab biosimilar, a monoclonal antibody used in the treatment of Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukaemia (CLL).

The partnership is an important step in expanding access to global standard-care treatment for two of the most prevalent types of blood cancer. The newly approved antibody addresses vital patient needs, while simultaneously supporting the sustainability of the Egyptian healthcare system.

A virtual scientific symposium will be held on 23 October to announce the availability of rituximab in Egypt.

“While NHL ranks 10th for men and 12th for women in terms of cancer incidence worldwide, in Egypt the risk of being diagnosed with the disease is even higher, with NHL representing the third most common cancer,” said Mohamed Abdel Moaaty Samra, Head of the Medical Oncology and Hematology Department, at Cairo University’s National Cancer Institute (NCI). “This launch is great news for Egyptian patients, making critical treatment more widely available to them.”

Samra added, “Rituximab is considered a standard of care and a first-line treatment in the management of many hematologic malignancies, and the approval of the first rituximab biosimilar in Egypt offers a substantially more affordable yet equally effective treatment alternative.”

By freeing up budgets, biosimilars help make funds available to treat other devastating illnesses, thereby supporting the sustainability of the healthcare system, while at the same time expanding access to treatment.

“Biosimilars are the successors of biologic medicines, known as ‘reference drugs’, with these therapies known to play a key role in the treatment of several cancers including lymphoma (Non-Hodgkin Lymphoma (NHL),” said Hamdy Abdel-Azim, Professor of Clinical Oncology at Cairo University’s Faculty of Medicine. “Unfortunately, the high cost of these reference biologicals represents a major challenge to patient access to treatment, a challenge that is encountered even in developed countries.”

Based on the latest reports issued by the World Health Organization (WHO), several million patients lack access to essential medicines. As a result, numerous biosimilar drugs have been introduced over the last few years that can provide equivalent safety and efficacy compared with their parent biological.

Sandoz’s rituximab biosimilar is one of these, and one of the first approved biosimilars in the treatment of NHL, with an unequivocally proven efficacy and safety in the treatment of these patients.

The use of rituximab in the treatment of NHL, could reduce about 40% of the total expenditure on treating the disease, compared to the use of the reference drug.“The launch of our first rituximab biosimilar in Egypt is a beacon of hope for many patients and represents a huge milestone for Sandoz. This launch is a testament to our commitment to expanding the availability of life changing and potentially lifesaving medications around the world,” said Sameh Elbagoury, Country Head for Sandoz Egypt and Libya.

“Rituximab is listed as one of the World Health Organization (WHO)’s essential biologic medicines for cancer patients and the introduction of the rituximab biosimilar by Sandoz represents a clear added value to the treatment of blood cancers in Egypt. Having demonstrated the same efficacy, safety, and quality in clinical trials as the reference medicine has, rituximab of Sandoz was approved by the European Medicines Agency (EMA) more than three years ago,” said Peter Effat, Medical Head for Sandoz Egypt.

You Might Also Like

Egypt to issue new bonds for climate, social goals

Saudi Public Investment Fund eyes stake in Palm Hills Development

UNDP, MBRF launch online learning initiative for Arab countries

Egypt Post invests in Roaderz platform to enhance e-commerce, delivery services

GAFI to grant 45 more golden licences to boost investment

TAGGED: blood cancer, ECS, Sandoz
Share this Article
Facebook Twitter Email Print
Previous Article AFD’s Proparco invests $11m in Egypt-focused LCP Fund II
Next Article Egypt, WBG cooperation portfolio amounts to $8bn
Ad image
Ad image

Stay Connected

Facebook Like
Twitter Follow
Instagram Follow
Youtube Subscribe

Latest News

Egypt to issue new bonds for climate, social goals
Egypt to issue new bonds for climate, social goals
Business
Saudi Public Investment Fund eyes stake in Palm Hills Development
Saudi Public Investment Fund eyes stake in Palm Hills Development
Business
Egypt’s Irrigation Minister highlights climate challenges for water sector
Egypt’s Irrigation Minister highlights climate challenges for water sector
Politics Egypt
CCCPA, Senghor University join forces for African peace, development
CCCPA, Senghor University join forces for African peace, development
Politics
//
Egypt’s only independent daily newspaper in English. Discuss the country’s latest with the paper’s reporters, editors, and other readers.

Quick Link

  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

© 2023 DNE News. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?